The 75 references without contexts in paper V. Liashenko A., В. Ляшенко А. (2014) “ЭКСПЕРИМЕНТАЛЬНЫЕ КОРЕВЫЕ ВАКЦИНЫ КАК ИНСТРУМЕНТ ИССЛЕДОВАНИЯ ВАКЦИНАЛЬНОГО ПРОЦЕССА // EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS” / spz:neicon:mimmun:y:2007:i:1:p:7-14

1
Александер С.К., Ляшенко В.А., Юминова Н.В., Михайлова А.А. Исследование иммунизирующих свойств живых вакцин против кори и эпидемического паротита на некоторых лабораторных животных // Эпидемиология
(check this in PDF content)
2
Белецкая Р.Г., Калюжная М.В., Ляшенко В.А., Ефремов М.А., Михайлова А.А. Миелопептид-2 – эндогенный иммуномодулятор, корригирующий функции поврежденных Т-лимфоцитов // Аллергия, астма и клиническая иммунология. –
(check this in PDF content)
3
Ляшенко В.А., Юминова Н.В., Краснова В.П. Особенности иммунного ответа взрослых добровольцев на интраназальную коревую вакцинацию // Иммунология. – 1993. – No 5. – С. 46-50.
(check this in PDF content)
4
Ляшенко В.А. Коревая иммунодепрессия в условиях инфекции и вакцинации // Иммунология. – 1996. – No 1. – С. 10-12.
(check this in PDF content)
5
Ляшенко В.А., Юминова Н.В., Краснова В.П. Неинъекционные методы использования живой коревой вакцины // Вопр. вирусологии. – 1996. – No 2. – С. -4--6.
(check this in PDF content)
6
Ляшенко В.А., Лавров В.Ф., Юминова Н.В., Ковалева Л.Г. Иммунодепрессивное действие вируса кори in vitro // Вопр. вирусологии. – 1999. – No 1. – С. 39-41. 1.
(check this in PDF content)
7
Ляшенко В.А., Юминова Н.В., Краснова В.П., Свирина В.С. Интраназальная ревакцинация детей живой коревой вакциной. Развитие местного иммунитета // Вопр. вирусологии. – 1999. – No 3. – С. 124-126.
(check this in PDF content)
8
Ляшенко В.А., Александер С.К., Ковалева Л.Г., Лавров В.Ф., Юминова Н.В. Ранние проявления иммуномодулирующего действия коревой вакцины в эксперименте in vitro // Медицинская иммунология. – 2002. – Т. 4. – No 1. – С. 21-2-.
(check this in PDF content)
9
Ляшенко В.А., Михайлова А.А., Александер С.К., Юминова Н.В., Фонина Л.А., Колышкин В.М. Влияние миелопептида-2 на результаты иммунизации иммунизации морских свинок ЖКВ // Вопр. вирусологии. – 2004. – No 2. –
(check this in PDF content)
10
Максимов Н.Л., Букин Е.К., Агафонов А.П., Неверов А.А., Карпенко Л.И., Ильичов А.А., Игнатьев Г.М. ДНК-вакцинация кори в эксперименте: иммуногенность и безопасность // Вопр. вирусологии. – 2005. – No 1. – С. 4-9.
(check this in PDF content)
11
Петров Р.В., Михайлова А.А., Фонина Л.А., Степаненко Р.Н. Миелопептиды. – М.: «Наука», 2000. – 1-0 с.
(check this in PDF content)
12
Ярилин А.А. Основы иммунологии. – М.: «Медицина», 1999. – 600 с.
(check this in PDF content)
13
Bennett J.V., De Castro L.J., Valdespino-
(check this in PDF content)
14
Gomez J.L., Valdespino-Gomez J.L., GarciaGa rcia M.L., Islas-Romero R., Echaniz-Aviles G.,
(check this in PDF content)
15
Jimenez-Corona A., Sepulveda-Amor J. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responces than injected vaccines: randomized trials in Mexican schoolchildren // Bull. World Health Organ. – 2002. – Vol. -0, N 10. –
(check this in PDF content)
16
Bellanti J.L., Zeligs B.J., Mendez-Inocentio J., Garcia-Garcia M.L., Islas-Romero R., Omidvar B., Omidvar J., Kim G., de Castro J.F., Sepulveda A.J.,
(check this in PDF content)
17
Bellini V.J., Valdespino-Gomez J.L. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine // Vaccine. – 2004. – Vol. 22, Iss. 9-10. –
(check this in PDF content)
18
Binnendiik R.S. van, Poelen M.C., van
(check this in PDF content)
19
Amerongen G., de Vries P. , Osterhaus A.D. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies // J. Infect. Dis. – 199-. – Vol. 1-5, N 3. – P. 524-532.
(check this in PDF content)
20
Bouche F.B., Steinmetz A., Yanagi Y., Muller C.P. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy // Vaccine. – 2005. – Vol. 23, Iss. 1--1-. – P. 20-4-20--.
(check this in PDF content)
21
Brinckman U.G., Bancamp B., Reich A., Ter Meulen V., Liebert U.G. Efficacy of individual measles virus structural proteins in the protection -. -.
(check this in PDF content)
22
Cardoso A.I., Sixt N., Vallier A., Faiolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen // J. Virol. –
(check this in PDF content)
23
Chabot S., Brewer A., Lowell G., Plante M., Cyr S., Burt D.S., Ward B.J. A novel intranasal protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cellmediated immunity in mice // Vaccine. – 2005. –
(check this in PDF content)
24
Cutts F.I., Clements C.J., Bennett J.V. Alternative routes of measles immunization: a review // Biologicals. – 199-. – Vol. 25, N 3. – P. 323-33-.
(check this in PDF content)
25
Сoates A.L., Tipples G., Leung K., Gray M., Louca F. How many infective viral particles are necessary for successful mass measles immunization by aerosol // Vaccine. – 2006. – Vol. 24, Iss. 10. – P. 15---15-5.
(check this in PDF content)
26
Dilraj A., Cutts F.T., de Castro J.F., Wheeler J.G.,
(check this in PDF content)
27
Brown D., Roth C., Coovadia H.M., Bennett J.V. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomized trial // Lancet. – 2000. – Vol. 355, N 9206. – P. -9---03.
(check this in PDF content)
28
Drillen R., Spehner D., Kim A., Giraudon P. , Buckland R., Wild F., Lecocq J.P. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein // Proc.
(check this in PDF content)
29
Durbin A.P., Skiadopoulos M.H., McAuliffe J.M., Riggs J.M., Surman S.R., Collins P. L., Murphy B.R. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles
(check this in PDF content)
30
Ecunwe E.O. Immunization by inhalation of aerosolized measles vaccine // Ann. Trop. Ped. – 1990. – Vol. 10, N 2. – Р. 145-149.
(check this in PDF content)
31
Etchart N., Desmoulins P. O., Chemin K., Maliszewski C., Dubois B., Wild F., Kaiserlian D. Dendritic cells recruitment and in vivo priming of CD-+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles
(check this in PDF content)
32
Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., Bloom B.R. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector // J. Immunol. – 1999. – Vol. 162, N 3. – P. 1603-1610.
(check this in PDF content)
33
Fooks A.R., Jeevarajah D. , Wames A., Wilkin- son G.W., Clegg J.C. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene // Viral. Immunol. – 1996. – Vol. 9, N 2. – P. 65--1.
(check this in PDF content)
34
Freitag L.C., Clements J.D. Mucosal adjuvants // Vaccine. – 2005. – Vol. 23, Iss. 15. – P. 1-04-1 -13.
(check this in PDF content)
35
Gundel I., Weidinger G., Ter Meulen V.,
(check this in PDF content)
36
Heesemann J., Russmann H., Niewiesk S. Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis // J. Gen. Virol. – 2003. – Vol. -4 (Pt 4). – P. --5---9.
(check this in PDF content)
37
Hathaway L.J., Partidos C.D., Vohra P., Steward M.W. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally // Vaccine. – 1995. – Vol. 13, Iss. 16. – P. 1495-1500.
(check this in PDF content)
38
Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P. J., Sherry B., Trinhiery G., Griffin D.E. Mechanism of suppression of cell-mediated immunity by measles virus // Science. – 1996. – Vol. 2-3. – P. 22--231.
(check this in PDF content)
39
Hartter H., Brons N.H., Muller C.P. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies // J. Gen. Virol. – 2000. – Vol. -1 (Pt 3). –
(check this in PDF content)
40
Maggi T., Oggioni M.R., Medaglini D., Bianchi Bandinelli M.L., Soldateschi D., Wiesmuller K.H.,Muller C.P., Valensin P.E., Pozzi G. Expression of measles virus antigens in Streptococcus gordonii // New Microbiol. – 2000. – Vol. 23,
(check this in PDF content)
41
Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P. H., Siegrist C.A. DNA immunization circumvents deficient induction of T-helper type 1 and cytotoxic T-lymphocyte responses in neonates and during early
(check this in PDF content)
42
Niewiesk S., Ohnimus H., Schnorr JensJorg, Gotzelmann M., Schneider-Schaulies S.,
(check this in PDF content)
43
Jassoy C., Ter Meulen V. Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes // J. Gen. Virol. – 1999. – Vol. -0. – P. 2023-2029.
(check this in PDF content)
44
Obeid O.E., Stanley C.M., Steward M.W. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus // Virus Res. – 1996. – Vol. 42, N 1-2. –
(check this in PDF content)
45
Ogra P. L., Fishot M., Gallagher M.R. Viral vaccination via the mucosal routes // Rev. Infect. Dis. – 19-0. – Vol. 2, N 3. – P. 352-369. 2-. 29.
(check this in PDF content)
46
Okada H., Sato T.A., Katayama A., Higuchi K., Shichijo K., Tsuchiva T., Takayama N., Takeuchi Y., Abe T., Okabe N., Tashiro M. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with
(check this in PDF content)
47
Ovsyannikova I.G., Johnson K.L., Naylor S., Poland G.A. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1 0401 alleles induced by measles vaccine virus infection // J. Immunol. Methods. – 2000. – Vol. 246. – P. 1-12.
(check this in PDF content)
48
Ovsyannikova I.G., Johnson K.L., Naylor S., Muddiman D.C., Poland G.A. Naturally processed measles virus peptide eluted from class II HLADRB1*03 recognised by T-lymphocytes from human blood // Virology. – 2003. – Vol. 312. – P. 495-506.
(check this in PDF content)
49
Ovsyannikova I.G., Reid K.C., Jacobson R.M., Oberg A.L., Klee G.G., Poland J.A. Cytokine production patterns and antibody response to measles vaccine // Vaccine. – 2003 – Vol. 21, Iss. 25-26. – P. 3946-3953.
(check this in PDF content)
50
Ovsyannikova I.G., Johnson K.L., Muddiman D.C., Viercant R.A., Poland J.A. Identification and characterization of Novel Naturally Processed Measles Virus Class 11 HLA-DRB1 Peptides // J. Virol. – 2004. – Vol. --, N 1. – P. 42-51.
(check this in PDF content)
51
Partidos C.D., Pizza M., Rappuoli R., Steward M.W. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with
(check this in PDF content)
52
Pasetti M.F., Barry E.M., Losonsky G., Singh M., Medina-Moreno S.M., Polo J.M., Ulmer J., Robinson H., Sztein M.B. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles
(check this in PDF content)
53
Polack F.P., Lee S.H., Permar S., Manyara E., Nousari H.G., Jeng Y., Mustafa F., Valsamakis A., Adams R.J., Robinson H.L., Griffin D.E. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion
(check this in PDF content)
54
Poland J.A., Ovsyannikova I.G., Johson K.L., Naylor S. The role of mass spectrometry in vaccine development // Vaccine. – 2001 – Vol. 19. – P. 26922-00.
(check this in PDF content)
55
Poland J.A., Ovsyannicova I.G., Jacobson R.M., Viercant R.A., Jacobsen S.J., Pancratz V.S., Schade D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization // Vaccine. – 2002. – Vol. 20. – P. 430-43-.
(check this in PDF content)
56
Putz M.M., Ammerlaan W., Schneider F., Jung G., Muller C.P. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens // Vaccine. – 2004 – Vol. 22, Iss. 31-32. – P. 41-3-41-2.
(check this in PDF content)
57
Sabin A.B., Flores A.A., de Castro J.F.,
(check this in PDF content)
58
Sever J.L., Madden D.L., Shekarchi I., Albrecht P. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. 1. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines // JAMA – 19-3. –
(check this in PDF content)
59
Sauver J.L., Schade D.J., Viercant R.A., Jacobson R.M., Jacobsen S.J., Ovsiannicova I.G., Poland G.A. Association between measles antibody level and the protein structure of class II human leucocyte antigens // Hum. Immunol. – 2003. –
(check this in PDF content)
60
Schlereth B., Germann P. G., ter Meulen V.,
(check this in PDF content)
61
Niewiesk S. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection // J. Gen. Virol. – 2000. – Vol. -1 (Pt 5). – P. 1321-1325.
(check this in PDF content)
62
Schlender J., Schnorr J.J., Spielhoffer P., Cathomen T., Cattaneo R., Billeter M.A., Ter Meulen V., Schneider-Schaulies S. Interaction of measles virus glycoproteins with the surface of uninfected peripheral peripheral blood lymphocytes induces
(check this in PDF content)
63
Sharpe S., Fooks A., Lee J., Hayes K., Clegg C., Cranage M. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses // Virology. – 2002. – Vol. 293, N 2. –
(check this in PDF content)
64
Song M.K., Vindurampulle C.J., Capozzo A.V., Ulmner J., Polo J.M., Pasetti M.F., Barry E.M., Levine V.V. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or
(check this in PDF content)
65
Stittelaar K.J., Vos H.W., van Amerongen G.,
(check this in PDF content)
66
Kersten G.F., Osterhaus A.D., de Swart R.L. 49. 50. 51. 52.
(check this in PDF content)
67
Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates // Vaccine. – 2002. – Vol. 21, Iss. 3-4. – P. 155-15-.
(check this in PDF content)
68
Torres C.A., Yang K., Mustafa F., Robinson H.L. DNA immunization: effect of secretion of DNAexpressed hemagglutinins on antibody responses // Vaccine. – 1999. – Vol. 1-, Iss. 9-10. – P. -05--14.
(check this in PDF content)
69
Wong-Chew R.M., Islas-Romero R., GarciaGarcia Mde L, Beeler J.A., Audet S., Santos-Presiado I.L., Gans H., Lew-Yasukawa L, Maldonado Y.A.,
(check this in PDF content)
70
Arvin A.M., Valdespino-Gomez J.L. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children // Vaccine. – 2006. – Vol. 24, Iss. 5. – P. 6-3-690.
(check this in PDF content)
71
Weidinger G., Ohlmann M., Schlereth B., Sutter G., Niewiesk S. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model // Vaccine. – 2001 – Vol. 19, Iss. 20-22. – P. 2-64-2 -6-.
(check this in PDF content)
72
Wild T.F., Bemard A., Spehner D., Drillien R. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice // J. Gen. Virol. – 1992. – Vol. -3 (Pt 2). – P. 359-36-.
(check this in PDF content)
73
Yang K., Mustafa F., Valsamakis A., Santoro J.C., Griffin D.E., Robinson H.L. Early studies on DNAbased immunizations for measles virus // Vaccine. – 199-. – Vol. 15, Iss. -. – P. -----91.
(check this in PDF content)
74
Zhu Y.D., Fennelly G., Miller C., Tarara R., Saxe I., Bloom B., McChesney M. Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia // J. Infect. Dis. – 199-. –
(check this in PDF content)
75
Zhu Y., Rota P. , Wyatt L., Tamin A., Rosenblatt S., Lerche N., Moss B., Bellini W., McChesney M. Evaluation of recombinant vaccinia virus – measles vaccines in infant rhesus macaques with preexisting measles antibody // Virology. – 2000. – Vol. 2-6,
(check this in PDF content)